Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Payables (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Payables for 16 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Payables fell 35.47% year-over-year to $2.0 million, compared with a TTM value of $2.0 million through Sep 2025, down 35.47%, and an annual FY2024 reading of $3.1 million, down 34.1% over the prior year.
  • Payables was $2.0 million for Q3 2025 at Rockwell Medical, down from $2.2 million in the prior quarter.
  • Across five years, Payables topped out at $6.7 million in Q2 2023 and bottomed at $2.0 million in Q3 2025.
  • Average Payables over 5 years is $4.1 million, with a median of $4.2 million recorded in 2022.
  • The sharpest move saw Payables soared 49.63% in 2023, then tumbled 59.5% in 2025.
  • Year by year, Payables stood at $4.2 million in 2021, then rose by 9.1% to $4.6 million in 2022, then grew by 4.48% to $4.8 million in 2023, then plummeted by 34.1% to $3.1 million in 2024, then plummeted by 36.72% to $2.0 million in 2025.
  • Business Quant data shows Payables for RMTI at $2.0 million in Q3 2025, $2.2 million in Q2 2025, and $2.0 million in Q1 2025.